Research and Development
FDA approves MSD’s Keytruda for head and neck cancer treatment
August 8, 2016 Manufacturing and Production, Research and Development Cancer, FDA, MSD, keytruda
SMC reverses decision on Opdivo in advanced skin cancer
August 8, 2016 Manufacturing and Production, Research and Development SMC, Scottish Medicines Consortium, melanoma, opdivo, skin cancer
Apellis Pharmaceuticals appoints Dr Robert Kim as CMO
August 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apellis, CMO, GSK, Novartis, appointment
AbbVie files lawsuit against Amgen over Humira copy
August 8, 2016 Research and Development, Sales and Marketing AbbVie, Amgen, FDA, Humira, rheumatoid arthritis
The power of PrEP
August 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PrEP, high court, lifestyle drug
‘Game changer’ asthma pill sees significant reduction in severe symptoms
August 8, 2016 Research and Development, Sales and Marketing Fevipiprant, Novartis, asthma, university of Leicester
Shock for BMS as Opdivo misses goal in late-stage lung cancer trial
August 5, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Checkmate, lung cancer, opdivo
Top ten stories in the pharmaceutical industry this week
August 5, 2016 Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten
Novo Nordisk diabetes drug Victoza fails to reduce heart failure risk
August 5, 2016 Medical Communications, Research and Development Eli Lily, Novo Nordisk, Victoza, diabetes, heart failure
Majority of US patients’ groups supporting pharma against Medicare reforms received industry funding, claims report
August 5, 2016 Medical Communications, Research and Development medicare reform, patients' groups, public citizen
Eylea sales jump helps boost Regeneron in Q2 results
August 5, 2016 Medical Communications, Research and Development 2016, Eylea, Q2, Regeneron, results
NICE recommends Cosentyx in ankylosing spondylitis
August 4, 2016 Research and Development, Sales and Marketing Cosentyx, NICE, Novartis, ankylosing spondylitis
NIH launches test of investigational human Zika vaccine
August 4, 2016 Research and Development Vaccine, Zika virus
FDA determines Xiamen Origin Biotech wilfully lied to inspectors and customers
August 4, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Xiamen Origin Biotech
Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial
August 4, 2016 Research and Development Adaptimmune, T cell, oncology, t-cell
